These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16516001)

  • 1. Risk factors for the development of prostate brachytherapy related urethral strictures.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Allen ZA; Adamovich E
    J Urol; 2006 Apr; 175(4):1376-80; discussion 1381. PubMed ID: 16516001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urethral stricture following high dose rate brachytherapy for prostate cancer.
    Sullivan L; Williams SG; Tai KH; Foroudi F; Cleeve L; Duchesne GM
    Radiother Oncol; 2009 May; 91(2):232-6. PubMed ID: 19097660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dosimetry of prostate brachytherapy-induced urethral strictures.
    Merrick GS; Butler WM; Tollenaar BG; Galbreath RW; Lief JH
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):461-8. PubMed ID: 11872293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy.
    Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
    Niehaus A; Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Adamovich E
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):136-43. PubMed ID: 16198062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity.
    Allen ZA; Merrick GS; Butler WM; Wallner KE; Kurko B; Anderson RL; Murray BC; Galbreath RW
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):981-7. PubMed ID: 15989998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between prostate brachytherapy-related urethral stricture and peri-apical urethral dosimetry: a matched case-control study.
    Earley JJ; Abdelbaky AM; Cunningham MJ; Chadwick E; Langley SE; Laing RW
    Radiother Oncol; 2012 Aug; 104(2):187-91. PubMed ID: 22841018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
    Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
    Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of radiation dose to the urethra on brachytherapy-related dysuria.
    Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Lief JH; Reed DJ
    Brachytherapy; 2005; 4(1):45-50. PubMed ID: 15737906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relationship between prostate brachytherapy and the diagnosis of colorectal cancer.
    Gutman SA; Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Adamovich E
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):48-55. PubMed ID: 16750312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Murray B; Allen Z; Lief JH; Galbreath RW
    Brachytherapy; 2004; 3(1):22-9. PubMed ID: 15110310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Cleavinger S
    Brachytherapy; 2003; 2(3):147-57. PubMed ID: 15062137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Adamovich E
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):669-77. PubMed ID: 16682149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity is not predictive of overall survival following permanent prostate brachytherapy.
    Merrick GS; Galbreath RW; Butler WM; Wallner KE; Allen ZA; Adamovich E
    Am J Clin Oncol; 2007 Dec; 30(6):588-96. PubMed ID: 18091052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors.
    Hindson BR; Millar JL; Matheson B
    Brachytherapy; 2013; 12(1):50-5. PubMed ID: 22561217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of recurrence of urethral stricture disease following optical urethrotomy.
    Zehri AA; Ather MH; Afshan Q
    Int J Surg; 2009 Aug; 7(4):361-4. PubMed ID: 19500695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
    Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
    BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
    Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
    Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.